Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Cephalon, Inc.
Ticker:ceph
Yahoo Beta:1.11
Industry:Biotechnology and Drugs

Company Description:  Cephalon, Inc. is an international biopharmaceutical company focused on the discovery, development and marketing of products to treat sleep disorders, neurological disorders, cancer and pain.

Purchase Date:13 Mar 2002 Sale Date:16 Apr 2003
Purchase Price:$64.55 Sale Price:$38.57
  --Split Adjusted:$64.55  --Split Adjusted:$38.57
Shares Purchased:60 Shares Sold:60
  --Split Adjusted:60  --Split Adjusted:60
Transaction Fee:$74.87 Transaction Fee:$64.96
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$77.58 High$0.00
Date28 Dec 2001 Date01 Jan 1996
Low$44.81 Low$0.00
Date21 Sep 2001 Date01 Jan 1996
S&P (Purchase Date):$1,154.09 S&P (Sale Date):$879.91

Purchase
Timing:  Stock seems to be on the rise slightly.
Reason:  We felt this is a rapid growth company. The price range concensus by multiple analyst is in the $80 range, which we feel the price will return to.

Sale
Timing:  
Reason:  The stock has not performed well recently and the company just received an unfavorable court decision significantly shortening the patent life of the company?s best selling drug.

S&P Gain: -23.76 % Annualized Gain: -23.59%
Stock Gain: -40.25 % Annualized Gain: -40%

Dividends:$0.00
Net Holding Return ($): $-1,698.63
Net Holding Return (%): -43.03 %